Christopher M Haqq

8PUBLICATIONS
23CO-AUTHORS
Innate immunityTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
Lymph node-targeted DNA engages TBK1/IFN-I-driven innate immunity to induce potent T cell responses and durable memory in mice and NHPs.

|Aug 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.

Zev A Wainberg, Colin D Weekes, Muhammad Furqan

|Jan 25, 2024
Lymph Node-Targeted Vaccine Boosting of TCR T-cell Therapy Enhances Antitumor Function and Eradicates Solid Tumors.

Dylan J Drakes, Abdulraouf M Abbas, Jacqueline Shields

|Jan 09, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

Shubham Pant, Zev A Wainberg, Colin D Weekes

|Aug 08, 2023
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.

Vijayendra Dasari, Lisa K McNeil, Kirrilee Beckett

|Oct 28, 2022
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates.

Lochana M Seenappa, Aniela Jakubowski, Martin P Steinbuck

Pageof 2

Frequent Collaborators

4 joint publications

Martin P Steinbuck

4 joint publications

Peter C DeMuth

3 joint publications

Lochana M Seenappa

3 joint publications

Aniela Jakubowski